Advertisement

Reactions Weekly

, Volume 1694, Issue 1, pp 193–193 | Cite as

Erlotinib/osimertinib

Interstitial lung disease and development of resistance to erlotinib resulting in transformation of adenocarcinoma to squamous cell carcinoma: case report
Case report
  • 15 Downloads

Reference

  1. Izumi H, et al. Squamous Cell Carcinoma Transformation from EGFR-mutated Lung Adenocarcinoma: A Case Report and Literature Review. Clinical Lung Cancer 19: e63-e66, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1016/j.cllc.2017.10.005 - Japan

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations